Value Based Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Model (Accountable Care Organization, Patient-Centered Medical Home, Pay for Performance, Bundled Payments), By Deployment (Cloud, On-premises), By End User (Hospitals, Clinics, Insurance Companies, Government, Others), By Region & Competition, 2021-2031F
The Global Value Based Healthcare Market is projected to expand from USD 1.89 Trillion in 2025 to USD 2.94 Trillion by 2031, reflecting a CAGR of 7.64%. This delivery model functions by compensating providers based on the quality of care and patient health outcomes achieved, rather than the quantity of services performed. The market is primarily driven by the critical need to curb rising healthcare costs and the increasing incidence of chronic diseases demanding coordinated management. These factors demand a fundamental transition toward financial efficiency and superior patient outcomes, moving beyond fleeting technological trends. Reflecting this shift, the National Association of ACOs noted that in 2025, 64% of healthcare organizations anticipated increased revenue from value-based care arrangements compared to the prior year.
One major obstacle hindering wider market expansion is the significant financial risk involved in shifting away from traditional reimbursement structures. Providers frequently struggle with the potential downside liabilities found in value-based contracts due to insufficient capital reserves or inadequate data infrastructure. This financial exposure causes smaller organizations to hesitate in abandoning guaranteed fee-for-service revenue streams, thereby slowing the widespread adoption of accountable care frameworks across the global market.
Market Driver
Legislative mandates and government initiatives promoting value-based models act as the primary catalyst for market growth. Federal authorities are actively directing the industry away from volume-based care by establishing programs that penalize underperformance while rewarding cost efficiency. These regulatory structures alleviate the strain of rising national health expenditures and compel healthcare institutions to implement accountable care frameworks. The demonstrated success of these mandates strengthens the business case for participation; for instance, the Centers for Medicare & Medicaid Services reported in September 2025 that the 'Medicare Shared Savings Program' generated $2.4 billion in net savings for the government during the 2024 performance year, confirming the financial viability of state-led interventions.
The strategic alignment of incentives between payers and providers is effectively hastening the shift from fee-for-service to pay-for-performance reimbursement. Payers are increasingly designing contracts that provide significant upside potential for providers who can demonstrate superior clinical outcomes and population health management. This financial alignment motivates physicians to prioritize preventive care and chronic disease management rather than episodic treatment. According to Humana Inc.'s 'Value-Based Care Report' from February 2025, providers in value-based Medicare Advantage arrangements earned up to 241% above the standard Medicare fee schedule, underscoring the profitability of these aligned incentives. Furthermore, this structural shift is gaining momentum; Optum data from 2025 indicates that approximately 14% of United States healthcare payments were linked to capitated risk models, marking a twofold increase since 2021.
Market Challenge
The considerable financial risk associated with moving from traditional reimbursement models to value-based care constitutes a critical impediment to the expansion of the Global Value Based Healthcare Market. Under value-based agreements, providers must often assume downside liability, meaning they are financially accountable if care costs surpass established benchmarks. This model demands substantial upfront capital reserves to absorb potential losses and requires costly infrastructure to track patient outcomes precisely. For many healthcare entities, especially smaller independent practices and rural hospitals, the possibility of owing funds back to payers presents an unmanageable hazard that outweighs the potential for shared savings.
This reluctance to accept financial exposure directly slows the market's growth momentum by discouraging broad participation in accountable care frameworks. When providers remain tethered to fee-for-service models to secure predictable revenue, the scalable adoption of value-based contracts stalls globally. The impact of this barrier is highlighted by recent industry findings; according to the National Association of ACOs in 2025, 87% of healthcare organizations identified financial risk as the primary barrier preventing the adoption of value-based care arrangements. Such elevated levels of apprehension suggest that until financial liabilities are more effectively mitigated, the market will struggle to achieve its projected growth rates.
Market Trends
The Integration of AI-Driven Predictive Analytics for Risk Stratification is fundamentally transforming how providers handle population health by facilitating the early detection of high-risk patients before expensive complications occur. Distinct from simple data aggregation, these sophisticated algorithms examine historical claims and clinical patterns to predict adverse events, such as hospital readmissions or the progression of chronic diseases, enabling care teams to intervene proactively. This technological capacity is becoming a standard operational necessity for maximizing shared savings; according to the Office of the National Coordinator for Health Information Technology's September 2025 report, 'Hospital Trends in the Use, Evaluation, and Governance of Predictive AI,' 71% of hospitals reported integrating predictive AI into their electronic health records in 2024 to improve clinical decision-making.
Concurrently, the Incorporation of Social Determinants of Health into Reimbursement Frameworks marks a crucial evolution in value assessment, recognizing that non-medical factors such as housing stability and food security influence the majority of clinical outcomes. Payers are progressively modifying contract terms to reimburse for social interventions, moving beyond traditional fee-for-service codes to reward holistic patient support that lowers long-term utilization. Despite this strategic pivot, accurately capturing social risk data remains a significant growth area; according to Net Health's April 2025 report, 'Using ICD-10 Z Codes to Identify Social Determinants of Health,' only 1.9% of inpatient hospital admissions documented SDOH Z codes, underscoring the vast opportunity for organizations to enhance revenue capture by formalizing these essential data elements.
Key Market Players
In this report, the Global Value Based Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Value Based Healthcare Market.
Available Customizations:
Global Value Based Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
One major obstacle hindering wider market expansion is the significant financial risk involved in shifting away from traditional reimbursement structures. Providers frequently struggle with the potential downside liabilities found in value-based contracts due to insufficient capital reserves or inadequate data infrastructure. This financial exposure causes smaller organizations to hesitate in abandoning guaranteed fee-for-service revenue streams, thereby slowing the widespread adoption of accountable care frameworks across the global market.
Market Driver
Legislative mandates and government initiatives promoting value-based models act as the primary catalyst for market growth. Federal authorities are actively directing the industry away from volume-based care by establishing programs that penalize underperformance while rewarding cost efficiency. These regulatory structures alleviate the strain of rising national health expenditures and compel healthcare institutions to implement accountable care frameworks. The demonstrated success of these mandates strengthens the business case for participation; for instance, the Centers for Medicare & Medicaid Services reported in September 2025 that the 'Medicare Shared Savings Program' generated $2.4 billion in net savings for the government during the 2024 performance year, confirming the financial viability of state-led interventions.
The strategic alignment of incentives between payers and providers is effectively hastening the shift from fee-for-service to pay-for-performance reimbursement. Payers are increasingly designing contracts that provide significant upside potential for providers who can demonstrate superior clinical outcomes and population health management. This financial alignment motivates physicians to prioritize preventive care and chronic disease management rather than episodic treatment. According to Humana Inc.'s 'Value-Based Care Report' from February 2025, providers in value-based Medicare Advantage arrangements earned up to 241% above the standard Medicare fee schedule, underscoring the profitability of these aligned incentives. Furthermore, this structural shift is gaining momentum; Optum data from 2025 indicates that approximately 14% of United States healthcare payments were linked to capitated risk models, marking a twofold increase since 2021.
Market Challenge
The considerable financial risk associated with moving from traditional reimbursement models to value-based care constitutes a critical impediment to the expansion of the Global Value Based Healthcare Market. Under value-based agreements, providers must often assume downside liability, meaning they are financially accountable if care costs surpass established benchmarks. This model demands substantial upfront capital reserves to absorb potential losses and requires costly infrastructure to track patient outcomes precisely. For many healthcare entities, especially smaller independent practices and rural hospitals, the possibility of owing funds back to payers presents an unmanageable hazard that outweighs the potential for shared savings.
This reluctance to accept financial exposure directly slows the market's growth momentum by discouraging broad participation in accountable care frameworks. When providers remain tethered to fee-for-service models to secure predictable revenue, the scalable adoption of value-based contracts stalls globally. The impact of this barrier is highlighted by recent industry findings; according to the National Association of ACOs in 2025, 87% of healthcare organizations identified financial risk as the primary barrier preventing the adoption of value-based care arrangements. Such elevated levels of apprehension suggest that until financial liabilities are more effectively mitigated, the market will struggle to achieve its projected growth rates.
Market Trends
The Integration of AI-Driven Predictive Analytics for Risk Stratification is fundamentally transforming how providers handle population health by facilitating the early detection of high-risk patients before expensive complications occur. Distinct from simple data aggregation, these sophisticated algorithms examine historical claims and clinical patterns to predict adverse events, such as hospital readmissions or the progression of chronic diseases, enabling care teams to intervene proactively. This technological capacity is becoming a standard operational necessity for maximizing shared savings; according to the Office of the National Coordinator for Health Information Technology's September 2025 report, 'Hospital Trends in the Use, Evaluation, and Governance of Predictive AI,' 71% of hospitals reported integrating predictive AI into their electronic health records in 2024 to improve clinical decision-making.
Concurrently, the Incorporation of Social Determinants of Health into Reimbursement Frameworks marks a crucial evolution in value assessment, recognizing that non-medical factors such as housing stability and food security influence the majority of clinical outcomes. Payers are progressively modifying contract terms to reimburse for social interventions, moving beyond traditional fee-for-service codes to reward holistic patient support that lowers long-term utilization. Despite this strategic pivot, accurately capturing social risk data remains a significant growth area; according to Net Health's April 2025 report, 'Using ICD-10 Z Codes to Identify Social Determinants of Health,' only 1.9% of inpatient hospital admissions documented SDOH Z codes, underscoring the vast opportunity for organizations to enhance revenue capture by formalizing these essential data elements.
Key Market Players
- UnitedHealth Group
- Kaiser Permanente
- Aetna Inc.
- Optum
- Cleveland Clinic
- Mayo Clinic
- Cigna
- Humana
- BCBS
- DaVita
In this report, the Global Value Based Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Value Based Healthcare Market, By Model
- Accountable Care Organization
- Patient-Centered Medical Home
- Pay for Performance
- Bundled Payments
- Value Based Healthcare Market, By Deployment
- Cloud
- On-premises
- Value Based Healthcare Market, By End User
- Hospitals
- Clinics
- Insurance Companies
- Government
- Others
- Value Based Healthcare Market, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Value Based Healthcare Market.
Available Customizations:
Global Value Based Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VALUE BASED HEALTHCARE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Model (Accountable Care Organization, Patient-Centered Medical Home, Pay for Performance, Bundled Payments)
5.2.2. By Deployment (Cloud, On-premises)
5.2.3. By End User (Hospitals, Clinics, Insurance Companies, Government, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. NORTH AMERICA VALUE BASED HEALTHCARE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Model
6.2.2. By Deployment
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Value Based Healthcare Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Model
6.3.1.2.2. By Deployment
6.3.1.2.3. By End User
6.3.2. Canada Value Based Healthcare Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Model
6.3.2.2.2. By Deployment
6.3.2.2.3. By End User
6.3.3. Mexico Value Based Healthcare Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Model
6.3.3.2.2. By Deployment
6.3.3.2.3. By End User
7. EUROPE VALUE BASED HEALTHCARE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Model
7.2.2. By Deployment
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Value Based Healthcare Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Model
7.3.1.2.2. By Deployment
7.3.1.2.3. By End User
7.3.2. France Value Based Healthcare Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Model
7.3.2.2.2. By Deployment
7.3.2.2.3. By End User
7.3.3. United Kingdom Value Based Healthcare Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Model
7.3.3.2.2. By Deployment
7.3.3.2.3. By End User
7.3.4. Italy Value Based Healthcare Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Model
7.3.4.2.2. By Deployment
7.3.4.2.3. By End User
7.3.5. Spain Value Based Healthcare Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Model
7.3.5.2.2. By Deployment
7.3.5.2.3. By End User
8. ASIA PACIFIC VALUE BASED HEALTHCARE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Model
8.2.2. By Deployment
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Value Based Healthcare Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Model
8.3.1.2.2. By Deployment
8.3.1.2.3. By End User
8.3.2. India Value Based Healthcare Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Model
8.3.2.2.2. By Deployment
8.3.2.2.3. By End User
8.3.3. Japan Value Based Healthcare Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Model
8.3.3.2.2. By Deployment
8.3.3.2.3. By End User
8.3.4. South Korea Value Based Healthcare Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Model
8.3.4.2.2. By Deployment
8.3.4.2.3. By End User
8.3.5. Australia Value Based Healthcare Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Model
8.3.5.2.2. By Deployment
8.3.5.2.3. By End User
9. MIDDLE EAST & AFRICA VALUE BASED HEALTHCARE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Model
9.2.2. By Deployment
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Value Based Healthcare Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Model
9.3.1.2.2. By Deployment
9.3.1.2.3. By End User
9.3.2. UAE Value Based Healthcare Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Model
9.3.2.2.2. By Deployment
9.3.2.2.3. By End User
9.3.3. South Africa Value Based Healthcare Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Model
9.3.3.2.2. By Deployment
9.3.3.2.3. By End User
10. SOUTH AMERICA VALUE BASED HEALTHCARE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Model
10.2.2. By Deployment
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Value Based Healthcare Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Model
10.3.1.2.2. By Deployment
10.3.1.2.3. By End User
10.3.2. Colombia Value Based Healthcare Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Model
10.3.2.2.2. By Deployment
10.3.2.2.3. By End User
10.3.3. Argentina Value Based Healthcare Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Model
10.3.3.2.2. By Deployment
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL VALUE BASED HEALTHCARE MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. UnitedHealth Group
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Kaiser Permanente
15.3. Aetna Inc.
15.4. Optum
15.5. Cleveland Clinic
15.6. Mayo Clinic
15.7. Cigna
15.8. Humana
15.9. BCBS
15.10. DaVita
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VALUE BASED HEALTHCARE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Model (Accountable Care Organization, Patient-Centered Medical Home, Pay for Performance, Bundled Payments)
5.2.2. By Deployment (Cloud, On-premises)
5.2.3. By End User (Hospitals, Clinics, Insurance Companies, Government, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. NORTH AMERICA VALUE BASED HEALTHCARE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Model
6.2.2. By Deployment
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Value Based Healthcare Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Model
6.3.1.2.2. By Deployment
6.3.1.2.3. By End User
6.3.2. Canada Value Based Healthcare Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Model
6.3.2.2.2. By Deployment
6.3.2.2.3. By End User
6.3.3. Mexico Value Based Healthcare Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Model
6.3.3.2.2. By Deployment
6.3.3.2.3. By End User
7. EUROPE VALUE BASED HEALTHCARE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Model
7.2.2. By Deployment
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Value Based Healthcare Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Model
7.3.1.2.2. By Deployment
7.3.1.2.3. By End User
7.3.2. France Value Based Healthcare Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Model
7.3.2.2.2. By Deployment
7.3.2.2.3. By End User
7.3.3. United Kingdom Value Based Healthcare Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Model
7.3.3.2.2. By Deployment
7.3.3.2.3. By End User
7.3.4. Italy Value Based Healthcare Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Model
7.3.4.2.2. By Deployment
7.3.4.2.3. By End User
7.3.5. Spain Value Based Healthcare Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Model
7.3.5.2.2. By Deployment
7.3.5.2.3. By End User
8. ASIA PACIFIC VALUE BASED HEALTHCARE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Model
8.2.2. By Deployment
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Value Based Healthcare Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Model
8.3.1.2.2. By Deployment
8.3.1.2.3. By End User
8.3.2. India Value Based Healthcare Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Model
8.3.2.2.2. By Deployment
8.3.2.2.3. By End User
8.3.3. Japan Value Based Healthcare Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Model
8.3.3.2.2. By Deployment
8.3.3.2.3. By End User
8.3.4. South Korea Value Based Healthcare Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Model
8.3.4.2.2. By Deployment
8.3.4.2.3. By End User
8.3.5. Australia Value Based Healthcare Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Model
8.3.5.2.2. By Deployment
8.3.5.2.3. By End User
9. MIDDLE EAST & AFRICA VALUE BASED HEALTHCARE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Model
9.2.2. By Deployment
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Value Based Healthcare Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Model
9.3.1.2.2. By Deployment
9.3.1.2.3. By End User
9.3.2. UAE Value Based Healthcare Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Model
9.3.2.2.2. By Deployment
9.3.2.2.3. By End User
9.3.3. South Africa Value Based Healthcare Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Model
9.3.3.2.2. By Deployment
9.3.3.2.3. By End User
10. SOUTH AMERICA VALUE BASED HEALTHCARE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Model
10.2.2. By Deployment
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Value Based Healthcare Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Model
10.3.1.2.2. By Deployment
10.3.1.2.3. By End User
10.3.2. Colombia Value Based Healthcare Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Model
10.3.2.2.2. By Deployment
10.3.2.2.3. By End User
10.3.3. Argentina Value Based Healthcare Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Model
10.3.3.2.2. By Deployment
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL VALUE BASED HEALTHCARE MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. UnitedHealth Group
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Kaiser Permanente
15.3. Aetna Inc.
15.4. Optum
15.5. Cleveland Clinic
15.6. Mayo Clinic
15.7. Cigna
15.8. Humana
15.9. BCBS
15.10. DaVita
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
